Latest Blog: 9th January 2020

The Future of Cell and Gene Therapy Manufacturing Just Got Brighter

Advances in cell and gene therapies (CGT) offer the potential to transform medicine. They create an inflection point in the ability to treat and potentially cure many intractable illnesses. Since Novartis broke open the market in 2017 with Kymriah, followed a few months later by Gilead’s Yescarta, scientific development of CGT is booming [...]

Read in full